Dose Ranging Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of PF-06700841 Topical Cream in Participants With Mild or Moderate Atopic Dermatitis

NCT03903822 · clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
292
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Pfizer